Elizabeth A Barranco-Santana

Statistics

Publications

Citations

792

H-Index

Active since

2015

Affiliations

Ponce Health Sciences University(Current)

Mahidol University

Takeda (United States)

Mahidol Oxford Tropical Medicine Research Unit

University of Puerto Rico System

Elizabeth A Barranco-Santana is an author at Ponce Health Sciences University specializing in vaccine immunology, veterinary medicine, and infectious diseases.

Publications per year

2015–2024

Publications

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations

Medicine, Pharmacology, Pharmacotherapy +16

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study

Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilin-Rivera et al. · The Journal of Infectious Diseases · 2015 · 82 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial

Heather Platt, Christopher Bruno, Erik Buntinx et al. · The Lancet Infectious Diseases · 2024 · 53 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study

Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilín Rivera et al. · The Journal of Infectious Diseases · 2020 · 15 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–4 of 4